Exploring the amyloid degradation potential of nanoformulated carrageenan-bridging in vitro and in vivo perspectives
Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical compartments. Insulin amyloid (IA), sharing structural resemblances with amyloids linked to neurological disorders, acts as a prototype, while com...
Saved in:
| Published in | International journal of biological macromolecules Vol. 279; no. Pt 1; p. 134814 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier B.V
01.11.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical compartments. Insulin amyloid (IA), sharing structural resemblances with amyloids linked to neurological disorders, acts as a prototype, while compounds capable of degrading these fibrils hold promise as therapeutic agents for amyloidosis intervention. In this research, liposomal nanoformulated iota carrageenan (nCG) was formulated to disrupt insulin amyloids, demonstrating about a 17–20 % higher degradation efficacy compared to conventional carrageenan through thioflavin T fluorescence, dynamic light scattering analysis, and turbidity quantification. The biocompatibility of the nCG and nCG-treated insulin amyloids was evaluated through MTT assay, live-dead cell assay on V79 cells, and hemolysis testing on human blood samples to establish their safety for use in vitro. Zebrafish embryos were utilized to assess in vivo biocompatibility, while adult zebrafish were employed to monitor the degradation capacity of IA post subcutaneous injection, with fluorescence emitted by the fish captured via IVIS. This demonstrated that the formulated nCG exhibited superior anti-amyloid efficacy compared to carrageenan alone, while both materials demonstrated biocompatibility. Furthermore, through docking simulations, an exploration was conducted into the molecular mechanisms governing the inhibition of the target protein pancreatic insulin by carrageenan.
[Display omitted] |
|---|---|
| AbstractList | Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical compartments. Insulin amyloid (IA), sharing structural resemblances with amyloids linked to neurological disorders, acts as a prototype, while compounds capable of degrading these fibrils hold promise as therapeutic agents for amyloidosis intervention. In this research, liposomal nanoformulated iota carrageenan (nCG) was formulated to disrupt insulin amyloids, demonstrating about a 17-20 % higher degradation efficacy compared to conventional carrageenan through thioflavin T fluorescence, dynamic light scattering analysis, and turbidity quantification. The biocompatibility of the nCG and nCG-treated insulin amyloids was evaluated through MTT assay, live-dead cell assay on V79 cells, and hemolysis testing on human blood samples to establish their safety for use in vitro. Zebrafish embryos were utilized to assess in vivo biocompatibility, while adult zebrafish were employed to monitor the degradation capacity of IA post subcutaneous injection, with fluorescence emitted by the fish captured via IVIS. This demonstrated that the formulated nCG exhibited superior anti-amyloid efficacy compared to carrageenan alone, while both materials demonstrated biocompatibility. Furthermore, through docking simulations, an exploration was conducted into the molecular mechanisms governing the inhibition of the target protein pancreatic insulin by carrageenan. Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical compartments. Insulin amyloid (IA), sharing structural resemblances with amyloids linked to neurological disorders, acts as a prototype, while compounds capable of degrading these fibrils hold promise as therapeutic agents for amyloidosis intervention. In this research, liposomal nanoformulated iota carrageenan (nCG) was formulated to disrupt insulin amyloids, demonstrating about a 17-20 % higher degradation efficacy compared to conventional carrageenan through thioflavin T fluorescence, dynamic light scattering analysis, and turbidity quantification. The biocompatibility of the nCG and nCG-treated insulin amyloids was evaluated through MTT assay, live-dead cell assay on V79 cells, and hemolysis testing on human blood samples to establish their safety for use in vitro. Zebrafish embryos were utilized to assess in vivo biocompatibility, while adult zebrafish were employed to monitor the degradation capacity of IA post subcutaneous injection, with fluorescence emitted by the fish captured via IVIS. This demonstrated that the formulated nCG exhibited superior anti-amyloid efficacy compared to carrageenan alone, while both materials demonstrated biocompatibility. Furthermore, through docking simulations, an exploration was conducted into the molecular mechanisms governing the inhibition of the target protein pancreatic insulin by carrageenan.Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical compartments. Insulin amyloid (IA), sharing structural resemblances with amyloids linked to neurological disorders, acts as a prototype, while compounds capable of degrading these fibrils hold promise as therapeutic agents for amyloidosis intervention. In this research, liposomal nanoformulated iota carrageenan (nCG) was formulated to disrupt insulin amyloids, demonstrating about a 17-20 % higher degradation efficacy compared to conventional carrageenan through thioflavin T fluorescence, dynamic light scattering analysis, and turbidity quantification. The biocompatibility of the nCG and nCG-treated insulin amyloids was evaluated through MTT assay, live-dead cell assay on V79 cells, and hemolysis testing on human blood samples to establish their safety for use in vitro. Zebrafish embryos were utilized to assess in vivo biocompatibility, while adult zebrafish were employed to monitor the degradation capacity of IA post subcutaneous injection, with fluorescence emitted by the fish captured via IVIS. This demonstrated that the formulated nCG exhibited superior anti-amyloid efficacy compared to carrageenan alone, while both materials demonstrated biocompatibility. Furthermore, through docking simulations, an exploration was conducted into the molecular mechanisms governing the inhibition of the target protein pancreatic insulin by carrageenan. Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical compartments. Insulin amyloid (IA), sharing structural resemblances with amyloids linked to neurological disorders, acts as a prototype, while compounds capable of degrading these fibrils hold promise as therapeutic agents for amyloidosis intervention. In this research, liposomal nanoformulated iota carrageenan (nCG) was formulated to disrupt insulin amyloids, demonstrating about a 17–20 % higher degradation efficacy compared to conventional carrageenan through thioflavin T fluorescence, dynamic light scattering analysis, and turbidity quantification. The biocompatibility of the nCG and nCG-treated insulin amyloids was evaluated through MTT assay, live-dead cell assay on V79 cells, and hemolysis testing on human blood samples to establish their safety for use in vitro. Zebrafish embryos were utilized to assess in vivo biocompatibility, while adult zebrafish were employed to monitor the degradation capacity of IA post subcutaneous injection, with fluorescence emitted by the fish captured via IVIS. This demonstrated that the formulated nCG exhibited superior anti-amyloid efficacy compared to carrageenan alone, while both materials demonstrated biocompatibility. Furthermore, through docking simulations, an exploration was conducted into the molecular mechanisms governing the inhibition of the target protein pancreatic insulin by carrageenan. [Display omitted] |
| ArticleNumber | 134814 |
| Author | Girigoswami, Koyeli Deepika, Balasubramanian Udayakumar, Saranya Kanakaraj, Lakshmi Metkar, Sanjay Kisan Janani, Gopalarethinam Girigoswami, Agnishwar |
| Author_xml | – sequence: 1 givenname: Saranya surname: Udayakumar fullname: Udayakumar, Saranya organization: Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India – sequence: 2 givenname: Sanjay Kisan surname: Metkar fullname: Metkar, Sanjay Kisan email: sanjay.metkar@rutgers.edu organization: Department of Pharmacology, Physiology & Neuroscience, Rutgers, The State University of New Jersey, 205 South Orange Avenue, Newark, NJ 07103, USA – sequence: 3 givenname: Agnishwar surname: Girigoswami fullname: Girigoswami, Agnishwar email: dragnishwar@care.edu.in organization: Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India – sequence: 4 givenname: Balasubramanian surname: Deepika fullname: Deepika, Balasubramanian organization: Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India – sequence: 5 givenname: Gopalarethinam surname: Janani fullname: Janani, Gopalarethinam organization: Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India – sequence: 6 givenname: Lakshmi surname: Kanakaraj fullname: Kanakaraj, Lakshmi organization: Chettinad School of Pharmaceutical Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India – sequence: 7 givenname: Koyeli surname: Girigoswami fullname: Girigoswami, Koyeli email: koyelig@care.edu.in organization: Medical Bionanotechnology, Faculty of Allied Health Sciences, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Chettinad Health City, Kelambakkam, Chennai 603103, India |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39168227$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkMtu2zAQRYkiQeI8fiHgshs5fImUdi2CJA1goJtkTdDkyKUhkSpJG83fl4aSbrsazMydezHnCp2FGAChO0rWlFB5v1_7_dbHydg1I0ysKRcdFV_Qinaqbwgh_AytCBW06Sgnl-gq532dypZ2F-iS91R2jKkVKo9_5jEmH3a4_AJspvcxeocd7JJxpvgY8BwLhOLNiOOAgwlxiGk6jKaAw9akZHYAddxsk3e7k5EP-OhLitgEtzTHiGdIeQZb_BHyDTofzJjh9qNeo7enx9eHH83m5_PLw_dNY5loS9MLRTrWK0LA2kEI1zpmlSISCGXQEaecaI0SW24k7-RQt5zbgVGqjCWC8mv0dfGdU_x9gFz05LOFcTQB4iFrTvpWKlktq1QuUptizgkGPSc_mfSuKdEn4nqvP4nrE3G9EK-Hdx8Zh-0E7t_ZJ-Iq-LYIoH569JB0th6CBedT5aFd9P_L-Au02Zjr |
| Cites_doi | 10.1186/1472-6882-14-508 10.1016/j.ijbiomac.2020.02.274 10.1039/C9RA02130B 10.1016/j.colsurfb.2020.111051 10.1039/D2BM02078E 10.1002/mabi.202300100 10.3390/md18110583 10.1016/j.algal.2021.102593 10.1016/j.jab.2017.01.003 10.4103/JASI.JASI_45_19 10.3390/ijms21207659 10.1016/j.arabjc.2018.06.008 10.1111/j.1742-4658.2005.05025.x 10.1080/13506129.2016.1179183 10.1155/NP.2005.311 10.1002/polb.22259 10.3390/chemistry4010001 10.3390/ph17030366 10.1021/acschemneuro.3c00460 10.1016/j.ijbiomac.2018.02.029 10.3892/mmr.2016.6006 10.1021/jf803072r 10.1039/D2BM00359G 10.1038/s12276-021-00571-5 10.1016/j.msec.2015.07.017 10.1007/s40495-023-00348-6 10.3390/md20070419 10.4103/2230-8210.146879 10.1016/j.jdcr.2020.02.011 10.1016/j.bcab.2024.103109 10.1016/j.foodhyd.2023.109298 10.3390/nano10061232 10.1039/D2TB01856J 10.1016/j.msec.2016.09.049 10.1016/j.ijbiomac.2023.127857 10.1007/s12640-018-9978-z 10.1074/jbc.M313745200 10.1016/j.ijbiomac.2020.06.256 10.2174/1871527318666191021150002 10.1038/s41598-021-86001-y 10.1021/acsanm.3c01078 10.1038/s41598-022-25386-w |
| ContentType | Journal Article |
| Copyright | 2024 Elsevier B.V. Copyright © 2024 Elsevier B.V. All rights reserved. |
| Copyright_xml | – notice: 2024 Elsevier B.V. – notice: Copyright © 2024 Elsevier B.V. All rights reserved. |
| DBID | NPM AAYXX CITATION 7X8 |
| DOI | 10.1016/j.ijbiomac.2024.134814 |
| DatabaseName | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Chemistry |
| EISSN | 1879-0003 |
| ExternalDocumentID | 10_1016_j_ijbiomac_2024_134814 39168227 S0141813024056198 |
| Genre | Journal Article |
| GroupedDBID | --- --K --M .~1 0R~ 1B1 1RT 1~. 1~5 29J 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AACTN AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABFNM ABFRF ABGSF ABJNI ABMAC ABUDA ABXDB ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADUVX AEBSH AEFWE AEHWI AEKER AENEX AFJKZ AFKWA AFTJW AFXIZ AGHFR AGRDE AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC CS3 DU5 EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HLW HVGLF HZ~ IHE J1W KOM LX3 M41 MO0 N9A O-L O9- OAUVE OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SBG SCC SDF SDG SDP SES SEW SPCBC SSU SSZ T5K UHS UNMZH WUQ ~02 ~G- NPM AAYXX CITATION 7X8 |
| ID | FETCH-LOGICAL-c245t-9470829700eccf44d5d2c7706e012e80d7d45a74b3a6386fd2c33cf2117ac0413 |
| IEDL.DBID | AIKHN |
| ISSN | 0141-8130 1879-0003 |
| IngestDate | Sat Oct 26 01:56:32 EDT 2024 Wed Oct 16 15:13:32 EDT 2024 Sat Nov 02 12:30:00 EDT 2024 Sat Oct 12 15:52:56 EDT 2024 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | Pt 1 |
| Keywords | Thioflavin T Type II diabetes Neurodegenerative disease Amyloidosis Iota carrageenan Insulin amyloid Amyloid degradation |
| Language | English |
| License | Copyright © 2024 Elsevier B.V. All rights reserved. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c245t-9470829700eccf44d5d2c7706e012e80d7d45a74b3a6386fd2c33cf2117ac0413 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 39168227 |
| PQID | 3095676770 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_3095676770 crossref_primary_10_1016_j_ijbiomac_2024_134814 pubmed_primary_39168227 elsevier_sciencedirect_doi_10_1016_j_ijbiomac_2024_134814 |
| PublicationCentury | 2000 |
| PublicationDate | 2024-11-01 |
| PublicationDateYYYYMMDD | 2024-11-01 |
| PublicationDate_xml | – month: 11 year: 2024 text: 2024-11-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | International journal of biological macromolecules |
| PublicationTitleAlternate | Int J Biol Macromol |
| PublicationYear | 2024 |
| Publisher | Elsevier B.V |
| Publisher_xml | – name: Elsevier B.V |
| References | P. Gowtham, K. Girigoswami, A.D. Prabhu, P. Pallavi, A. Thirumalai, K. Harini, A. Girigoswami, Hydrogels of alginate derivative-encased nanodots featuring carbon-coated manganese ferrite cores with gold shells to offer antiangiogenesis with multimodal imaging-based theranostics, Adv. Ther. 2400054. Zainal Ariffin, Yeen, Zainol Abidin, Wahab, Ariffin, Senafi (bb0215) 2014; 14 Agraharam, Girigoswami, Girigoswami (bb0110) 2021; 4 Thirumalai, Harini, Pallavi, Gowtham, Girigoswami, Girigoswami (bb0120) 2024; 11 Bera, Ghosh, Barman, Bhattacharya, Sudhamalla, Goswami, De (bb0055) 2023; 11 Hsu, Lee, Wang, Lee, Chen (bb0125) 2009; 57 Bera, Ghosh, Ghosh, Mukherjee, De (bb0045) 2023; 23 Pacheco-Quito, Ruiz-Caro, Veiga (bb0090) 2020; 18 Samlaska, Reber, Murry (bb0030) 2020; 6 Wang, Feng, Tian, Li, Liu (bb0015) 2020; 192 Kalitnik, Grelich-Mucha, Olesiak-Bańska (bb0070) 2024; 254 Störkel, Schneider, Müntefering, Kashiwagi (bb0210) 1983; 48 Vergallo (bb0245) 2020; 10 Manigandan, Nataraj, Karthik, Manivasagam, Saravanan, Thenmozhi, Essa, Guillemin (bb0155) 2019; 35 Stepanenko, Sulatsky, Mikhailova, Stepanenko, Povarova, Kuznetsova, Turoverov, Sulatskaya (bb0190) 2020; 21 Rasool, Ata, Islam, Khan (bb0165) 2019; 9 Dey, Haldar, Rajasekhar, Ghosh, Faust, De (bb0040) 2022; 10 Yoshizaki, Maegawa, Egawa, Ugi, Nishio, Imamura, Kobayashi, Tamura, Olefsky, Kashiwagi (bb0175) 2004; 279 Jiang, Liu, Xiao, Chen, Weng, Chen, Zhang, Xiao (bb0085) 2022; 20 Prabhu, Jayakumari, Prabhu, Kumar, Subramanian (bb0065) 2019; 68 Metkar, Girigoswami, Murugesan, Girigoswami (bb0135) 2017; 70 Sun, Xu, Wang, Li, Bai, Dong, Wu, Yao (bb0230) 2023; 14 Makin, Serpell (bb0195) 2005; 272 Metkar, Udayakumar, Girigoswami, Girigoswami (bb0005) 2023; 13 Guo, Wei, Zhang, Xu, Zheng, Zhu, Yao (bb0080) 2022; 61 Metkar, Girigoswami, Vijayashree, Girigoswami (bb0010) 2020; 163 Volkov, Machikhin, Bukova, Khokhlov, Burlakov, Krylov (bb0225) 2022; 12 Bhattacharyya, Palla, Dethe, Joshi (bb0095) 2024; 146 Choi, Choi, Lee, Choe, Kim (bb0220) 2021; 53 Bera, Ghosh, Goswami, De (bb0050) 2023; 6 Messier, Teutenberg (bb0035) 2005; 12 Metkar, Girigoswami, Bondage, Shinde, Girigoswami (bb0185) 2022; 134 Gupta, Singla, Singla (bb0200) 2015; 19 Liu, Jiang, Li (bb0235) 2017; 15 Ulery, Nair, Laurencin (bb0105) 2011; 49 Metkar, Ghosh, Girigoswami, Girigoswami (bb0180) 2019; 18 Nusslein-Volhard, Dahm (bb0150) 2002 Deepika, Pallavi, Gowtham, Girigoswami, Girigoswami (bb0170) 2024; 57 Ghani, Othaman, Ahmad, Anuar, Hassan (bb0160) 2019; 12 Udayakumar, Girigoswami, Girigoswami (bb0075) 2024; 10 Souza, Frota, Silva, Alves, Neugebauer, Pinteus, Rodrigues, Cordeiro, de Almeida, Pedrosa (bb0240) 2018; 112 Metkar, Girigoswami, Murugesan, Girigoswami (bb0140) 2017; 15 Mori, Yuzu, Lobsiger, Nishioka, Sato, Nagase, Iwaya, Lindgren, Zako (bb0025) 2021; 11 Harini, Alomar, Vajagathali, Manoharadas, Thirumalai, Girigoswami, Girigoswami (bb0115) 2024; 17 Nilsson (bb0205) 2016; 23 Bera, Mukhopadhyay, Goswami, Ghosh, De, De (bb0060) 2022; 10 Kumar, Udgaonkar (bb0020) 2010; 98 Girigoswami, Viswanathan, Murugesan, Girigoswami (bb0145) 2015; 56 Madruga, Sabino, Santos, Popat, Balaban, Kipper (bb0100) 2020; 152 Thirumalai (10.1016/j.ijbiomac.2024.134814_bb0120) 2024; 11 Metkar (10.1016/j.ijbiomac.2024.134814_bb0005) 2023; 13 Manigandan (10.1016/j.ijbiomac.2024.134814_bb0155) 2019; 35 Ghani (10.1016/j.ijbiomac.2024.134814_bb0160) 2019; 12 Agraharam (10.1016/j.ijbiomac.2024.134814_bb0110) 2021; 4 Harini (10.1016/j.ijbiomac.2024.134814_bb0115) 2024; 17 Kalitnik (10.1016/j.ijbiomac.2024.134814_bb0070) 2024; 254 Deepika (10.1016/j.ijbiomac.2024.134814_bb0170) 2024; 57 Jiang (10.1016/j.ijbiomac.2024.134814_bb0085) 2022; 20 Girigoswami (10.1016/j.ijbiomac.2024.134814_bb0145) 2015; 56 Samlaska (10.1016/j.ijbiomac.2024.134814_bb0030) 2020; 6 Vergallo (10.1016/j.ijbiomac.2024.134814_bb0245) 2020; 10 Volkov (10.1016/j.ijbiomac.2024.134814_bb0225) 2022; 12 Bhattacharyya (10.1016/j.ijbiomac.2024.134814_bb0095) 2024; 146 Madruga (10.1016/j.ijbiomac.2024.134814_bb0100) 2020; 152 Sun (10.1016/j.ijbiomac.2024.134814_bb0230) 2023; 14 Ulery (10.1016/j.ijbiomac.2024.134814_bb0105) 2011; 49 Dey (10.1016/j.ijbiomac.2024.134814_bb0040) 2022; 10 Störkel (10.1016/j.ijbiomac.2024.134814_bb0210) 1983; 48 Kumar (10.1016/j.ijbiomac.2024.134814_bb0020) 2010; 98 Metkar (10.1016/j.ijbiomac.2024.134814_bb0185) 2022; 134 Zainal Ariffin (10.1016/j.ijbiomac.2024.134814_bb0215) 2014; 14 Bera (10.1016/j.ijbiomac.2024.134814_bb0045) 2023; 23 Liu (10.1016/j.ijbiomac.2024.134814_bb0235) 2017; 15 Yoshizaki (10.1016/j.ijbiomac.2024.134814_bb0175) 2004; 279 Nusslein-Volhard (10.1016/j.ijbiomac.2024.134814_bb0150) 2002 Prabhu (10.1016/j.ijbiomac.2024.134814_bb0065) 2019; 68 Bera (10.1016/j.ijbiomac.2024.134814_bb0055) 2023; 11 Choi (10.1016/j.ijbiomac.2024.134814_bb0220) 2021; 53 Messier (10.1016/j.ijbiomac.2024.134814_bb0035) 2005; 12 10.1016/j.ijbiomac.2024.134814_bb0130 Mori (10.1016/j.ijbiomac.2024.134814_bb0025) 2021; 11 Pacheco-Quito (10.1016/j.ijbiomac.2024.134814_bb0090) 2020; 18 Guo (10.1016/j.ijbiomac.2024.134814_bb0080) 2022; 61 Stepanenko (10.1016/j.ijbiomac.2024.134814_bb0190) 2020; 21 Bera (10.1016/j.ijbiomac.2024.134814_bb0060) 2022; 10 Makin (10.1016/j.ijbiomac.2024.134814_bb0195) 2005; 272 Metkar (10.1016/j.ijbiomac.2024.134814_bb0135) 2017; 70 Metkar (10.1016/j.ijbiomac.2024.134814_bb0180) 2019; 18 Wang (10.1016/j.ijbiomac.2024.134814_bb0015) 2020; 192 Hsu (10.1016/j.ijbiomac.2024.134814_bb0125) 2009; 57 Gupta (10.1016/j.ijbiomac.2024.134814_bb0200) 2015; 19 Rasool (10.1016/j.ijbiomac.2024.134814_bb0165) 2019; 9 Nilsson (10.1016/j.ijbiomac.2024.134814_bb0205) 2016; 23 Metkar (10.1016/j.ijbiomac.2024.134814_bb0140) 2017; 15 Metkar (10.1016/j.ijbiomac.2024.134814_bb0010) 2020; 163 Souza (10.1016/j.ijbiomac.2024.134814_bb0240) 2018; 112 Bera (10.1016/j.ijbiomac.2024.134814_bb0050) 2023; 6 Udayakumar (10.1016/j.ijbiomac.2024.134814_bb0075) 2024; 10 |
| References_xml | – volume: 12 start-page: 370 year: 2019 end-page: 376 ident: bb0160 article-title: Impact of purification on iota carrageenan as solid polymer electrolyte publication-title: Arab. J. Chem. contributor: fullname: Hassan – volume: 163 start-page: 128 year: 2020 end-page: 134 ident: bb0010 article-title: Attenuation of subcutaneous insulin induced amyloid mass in vivo using Lumbrokinase and Serratiopeptidase publication-title: Int. J. Biol. Macromol. contributor: fullname: Girigoswami – volume: 10 start-page: 9446 year: 2022 end-page: 9456 ident: bb0040 article-title: Polyisobutylene-based glycopolymers as potent inhibitors for in vitro insulin aggregation publication-title: J. Mater. Chem. B contributor: fullname: De – volume: 17 start-page: 366 year: 2024 ident: bb0115 article-title: Niosomal bupropion: exploring therapeutic frontiers through behavioral profiling publication-title: Pharmaceuticals contributor: fullname: Girigoswami – volume: 12 start-page: 20884 year: 2022 ident: bb0225 article-title: Optical transparency and label-free vessel imaging of zebrafish larvae in shortwave infrared range as a tool for prolonged studying of cardiovascular system development publication-title: Sci. Rep. contributor: fullname: Krylov – volume: 192 year: 2020 ident: bb0015 article-title: Disassembling and degradation of amyloid protein aggregates based on gold nanoparticle-modified g-C3N4 publication-title: Colloids Surf. B Biointerfaces contributor: fullname: Liu – volume: 254 year: 2024 ident: bb0070 article-title: Chitosan oligosaccharides inhibit the fibrillation of insulin and disassemble its preformed fibrils publication-title: Int. J. Biol. Macromol. contributor: fullname: Olesiak-Bańska – volume: 70 start-page: 728 year: 2017 end-page: 735 ident: bb0135 article-title: In vitro and in vivo insulin amyloid degradation mediated by Serratiopeptidase publication-title: Mater. Sci. Eng. C contributor: fullname: Girigoswami – volume: 15 start-page: 96 year: 2017 end-page: 104 ident: bb0140 article-title: Lumbrokinase for degradation and reduction of amyloid fibrils associated with amyloidosis publication-title: J. Appl. Biomed. contributor: fullname: Girigoswami – volume: 68 start-page: 269 year: 2019 end-page: 273 ident: bb0065 article-title: Saraswatarishta reverses neuronal injury in brain tissues of scopolamine-induced rat model publication-title: J. Anat. Soc. India contributor: fullname: Subramanian – volume: 20 start-page: 419 year: 2022 ident: bb0085 article-title: Eco-friendly extraction, structure, and gel properties of ι-carrageenan extracted using Ca (OH) 2 publication-title: Mar. Drugs contributor: fullname: Xiao – volume: 56 start-page: 501 year: 2015 end-page: 510 ident: bb0145 article-title: Studies on polymer-coated zinc oxide nanoparticles: UV-blocking efficacy and in vivo toxicity publication-title: Mater. Sci. Eng. C contributor: fullname: Girigoswami – volume: 279 start-page: 22715 year: 2004 end-page: 22726 ident: bb0175 article-title: Protein phosphatase-2Cα as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes* publication-title: J. Biol. Chem. contributor: fullname: Kashiwagi – volume: 14 start-page: 3540 year: 2023 end-page: 3550 ident: bb0230 article-title: κ-Carrageenan oligosaccharides protect nerves by regulating microglial autophagy in Alzheimer’s disease publication-title: ACS Chem. Nerosci. contributor: fullname: Yao – volume: 49 start-page: 832 year: 2011 end-page: 864 ident: bb0105 article-title: Biomedical applications of biodegradable polymers publication-title: J Polym Sci B contributor: fullname: Laurencin – year: 2002 ident: bb0150 article-title: Zebrafish contributor: fullname: Dahm – volume: 134 start-page: 1 year: 2022 end-page: 12 ident: bb0185 article-title: The potential of lumbrokinase and serratiopeptidase for the degradation of Aβ 1–42 peptide–an in vitro and in silico approach publication-title: Int. J. Neurosci. contributor: fullname: Girigoswami – volume: 18 start-page: 583 year: 2020 ident: bb0090 article-title: Carrageenan: drug delivery systems and other biomedical applications publication-title: Mar. Drugs contributor: fullname: Veiga – volume: 35 start-page: 505 year: 2019 end-page: 515 ident: bb0155 article-title: Low molecular weight sulfated chitosan: neuroprotective effect on rotenone-induced in vitro Parkinson’s disease publication-title: Neurotox. Res. contributor: fullname: Guillemin – volume: 98 start-page: 639 year: 2010 end-page: 656 ident: bb0020 article-title: Mechanisms of amyloid fibril formation by proteins publication-title: Curr. Sci. contributor: fullname: Udgaonkar – volume: 11 year: 2024 ident: bb0120 article-title: Bile salt-mediated surface-engineered bilosome-nanocarriers for delivering therapeutics publication-title: Nanomed. J. contributor: fullname: Girigoswami – volume: 152 start-page: 483 year: 2020 end-page: 491 ident: bb0100 article-title: Carboxymethyl-kappa-carrageenan: a study of biocompatibility, antioxidant and antibacterial activities publication-title: Int. J. Biol. Macromol. contributor: fullname: Kipper – volume: 272 start-page: 5950 year: 2005 end-page: 5961 ident: bb0195 article-title: Structures for amyloid fibrils publication-title: FEBS J. contributor: fullname: Serpell – volume: 19 start-page: 174 year: 2015 ident: bb0200 article-title: Insulin-derived amyloidosis publication-title: Indian J. Endocrinol. Metab. contributor: fullname: Singla – volume: 14 start-page: 1 year: 2014 end-page: 16 ident: bb0215 article-title: Cytotoxicity effect of degraded and undegraded kappa and iota carrageenan in human intestine and liver cell lines publication-title: BMC Complement. Altern. Med. contributor: fullname: Senafi – volume: 48 start-page: 108 year: 1983 end-page: 111 ident: bb0210 article-title: Iatrogenic, insulin-dependent, local amyloidosis publication-title: Lab. Investig. J. Techn. Methods Pathol. contributor: fullname: Kashiwagi – volume: 9 start-page: 12282 year: 2019 end-page: 12290 ident: bb0165 article-title: Fabrication of novel carrageenan based stimuli responsive injectable hydrogels for controlled release of cephradine publication-title: RSC Adv. contributor: fullname: Khan – volume: 23 start-page: 2300100 year: 2023 ident: bb0045 article-title: Antioxidant polymers with enhanced neuroprotection against insulin fibrillation publication-title: Macromol. Biosci. contributor: fullname: De – volume: 10 start-page: 12 year: 2024 end-page: 26 ident: bb0075 article-title: Biological activities of carrageenan from red algae: a mini review publication-title: Curr. Pharmacol. Rep. contributor: fullname: Girigoswami – volume: 57 start-page: 503 year: 2009 end-page: 508 ident: bb0125 article-title: Amyloid-degrading ability of nattokinase from Bacillus subtilis natto publication-title: J. Agric. Food Chem. contributor: fullname: Chen – volume: 21 start-page: 7659 year: 2020 ident: bb0190 article-title: Alpha-b-crystallin effect on mature amyloid fibrils: different degradation mechanisms and changes in cytotoxicity publication-title: Int. J. Mol. Sci. contributor: fullname: Sulatskaya – volume: 112 start-page: 1248 year: 2018 end-page: 1256 ident: bb0240 article-title: In vitro activities of kappa-carrageenan isolated from red marine alga Hypnea musciformis: antimicrobial, anticancer and neuroprotective potential publication-title: Int. J. Biol. Macromol. contributor: fullname: Pedrosa – volume: 18 start-page: 723 year: 2019 end-page: 731 ident: bb0180 article-title: Prion peptide 106-126 degradation potential of Serratiopetidase and lumbrokinase-an in vitro and in silico perspective publication-title: CNS Neurol. Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS Neurol. Disorders) contributor: fullname: Girigoswami – volume: 10 start-page: 1232 year: 2020 ident: bb0245 article-title: Nutraceutical vegetable oil nanoformulations for prevention and management of diseases publication-title: Nanomaterials contributor: fullname: Vergallo – volume: 4 start-page: 1 year: 2021 end-page: 17 ident: bb0110 article-title: Nanoencapsulated myricetin to improve antioxidant activity and bioavailability: a study on zebrafish embryos publication-title: Chemistry contributor: fullname: Girigoswami – volume: 11 start-page: 6857 year: 2021 ident: bb0025 article-title: Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates publication-title: Sci. Rep. contributor: fullname: Zako – volume: 15 start-page: 285 year: 2017 end-page: 290 ident: bb0235 article-title: κ-Carrageenan-derived pentasaccharide attenuates Aβ25-35-induced apoptosis in SH-SY5Y cells via suppression of the JNK signaling pathway publication-title: Mol. Med. Rep. contributor: fullname: Li – volume: 6 start-page: 8705 year: 2023 end-page: 8716 ident: bb0050 article-title: Amino acid-based polymer-coated silver nanoparticles as insulin fibril inhibitors publication-title: ACS Appl. Nano Mater. contributor: fullname: De – volume: 10 start-page: 3466 year: 2022 end-page: 3479 ident: bb0060 article-title: Fatty acid-based polymeric micelles to ameliorate amyloidogenic disorders publication-title: Biomater. Sci. contributor: fullname: De – volume: 6 start-page: 351 year: 2020 end-page: 353 ident: bb0030 article-title: Insulin-derived amyloidosis: the insulin ball, amyloidoma publication-title: JAAD Case Rep. contributor: fullname: Murry – volume: 146 year: 2024 ident: bb0095 article-title: Rheological investigation of the network structure in mixed gels of kappa and iota carrageenan publication-title: Food Hydrocoll. contributor: fullname: Joshi – volume: 11 start-page: 3574 year: 2023 end-page: 3588 ident: bb0055 article-title: Insulin fibril inhibition using glycopolymeric nanoassemblies publication-title: Biomater. Sci. contributor: fullname: De – volume: 53 start-page: 310 year: 2021 end-page: 317 ident: bb0220 article-title: Zebrafish as an animal model for biomedical research publication-title: Exp. Mol. Med. contributor: fullname: Kim – volume: 23 start-page: 139 year: 2016 end-page: 147 ident: bb0205 article-title: Insulin amyloid at injection sites of patients with diabetes publication-title: Amyloid contributor: fullname: Nilsson – volume: 57 year: 2024 ident: bb0170 article-title: Anticancer potential of nanoformulated extract of Passiflora incarnata leaves publication-title: Biocatal. Agric. Biotechnol. contributor: fullname: Girigoswami – volume: 13 year: 2023 ident: bb0005 article-title: Amyloidosis-history and development, emphasis on insulin and prion amyloids publication-title: Brain Disorders contributor: fullname: Girigoswami – volume: 12 start-page: 311 year: 2005 end-page: 328 ident: bb0035 article-title: The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease publication-title: Neural Plast. contributor: fullname: Teutenberg – volume: 61 year: 2022 ident: bb0080 article-title: Carrageenan oligosaccharides: a comprehensive review of preparation, isolation, purification, structure, biological activities and applications publication-title: Algal Res. contributor: fullname: Yao – volume: 14 start-page: 1 year: 2014 ident: 10.1016/j.ijbiomac.2024.134814_bb0215 article-title: Cytotoxicity effect of degraded and undegraded kappa and iota carrageenan in human intestine and liver cell lines publication-title: BMC Complement. Altern. Med. doi: 10.1186/1472-6882-14-508 contributor: fullname: Zainal Ariffin – volume: 152 start-page: 483 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0100 article-title: Carboxymethyl-kappa-carrageenan: a study of biocompatibility, antioxidant and antibacterial activities publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2020.02.274 contributor: fullname: Madruga – volume: 9 start-page: 12282 issue: 22 year: 2019 ident: 10.1016/j.ijbiomac.2024.134814_bb0165 article-title: Fabrication of novel carrageenan based stimuli responsive injectable hydrogels for controlled release of cephradine publication-title: RSC Adv. doi: 10.1039/C9RA02130B contributor: fullname: Rasool – volume: 192 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0015 article-title: Disassembling and degradation of amyloid protein aggregates based on gold nanoparticle-modified g-C3N4 publication-title: Colloids Surf. B Biointerfaces doi: 10.1016/j.colsurfb.2020.111051 contributor: fullname: Wang – volume: 11 start-page: 3574 issue: 10 year: 2023 ident: 10.1016/j.ijbiomac.2024.134814_bb0055 article-title: Insulin fibril inhibition using glycopolymeric nanoassemblies publication-title: Biomater. Sci. doi: 10.1039/D2BM02078E contributor: fullname: Bera – volume: 23 start-page: 2300100 issue: 7 year: 2023 ident: 10.1016/j.ijbiomac.2024.134814_bb0045 article-title: Antioxidant polymers with enhanced neuroprotection against insulin fibrillation publication-title: Macromol. Biosci. doi: 10.1002/mabi.202300100 contributor: fullname: Bera – volume: 48 start-page: 108 issue: 1 year: 1983 ident: 10.1016/j.ijbiomac.2024.134814_bb0210 article-title: Iatrogenic, insulin-dependent, local amyloidosis publication-title: Lab. Investig. J. Techn. Methods Pathol. contributor: fullname: Störkel – volume: 13 year: 2023 ident: 10.1016/j.ijbiomac.2024.134814_bb0005 article-title: Amyloidosis-history and development, emphasis on insulin and prion amyloids publication-title: Brain Disorders contributor: fullname: Metkar – volume: 11 issue: 1 year: 2024 ident: 10.1016/j.ijbiomac.2024.134814_bb0120 article-title: Bile salt-mediated surface-engineered bilosome-nanocarriers for delivering therapeutics publication-title: Nanomed. J. contributor: fullname: Thirumalai – year: 2002 ident: 10.1016/j.ijbiomac.2024.134814_bb0150 contributor: fullname: Nusslein-Volhard – volume: 18 start-page: 583 issue: 11 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0090 article-title: Carrageenan: drug delivery systems and other biomedical applications publication-title: Mar. Drugs doi: 10.3390/md18110583 contributor: fullname: Pacheco-Quito – volume: 61 year: 2022 ident: 10.1016/j.ijbiomac.2024.134814_bb0080 article-title: Carrageenan oligosaccharides: a comprehensive review of preparation, isolation, purification, structure, biological activities and applications publication-title: Algal Res. doi: 10.1016/j.algal.2021.102593 contributor: fullname: Guo – volume: 15 start-page: 96 issue: 2 year: 2017 ident: 10.1016/j.ijbiomac.2024.134814_bb0140 article-title: Lumbrokinase for degradation and reduction of amyloid fibrils associated with amyloidosis publication-title: J. Appl. Biomed. doi: 10.1016/j.jab.2017.01.003 contributor: fullname: Metkar – volume: 68 start-page: 269 issue: 4 year: 2019 ident: 10.1016/j.ijbiomac.2024.134814_bb0065 article-title: Saraswatarishta reverses neuronal injury in brain tissues of scopolamine-induced rat model publication-title: J. Anat. Soc. India doi: 10.4103/JASI.JASI_45_19 contributor: fullname: Prabhu – volume: 21 start-page: 7659 issue: 20 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0190 article-title: Alpha-b-crystallin effect on mature amyloid fibrils: different degradation mechanisms and changes in cytotoxicity publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms21207659 contributor: fullname: Stepanenko – volume: 12 start-page: 370 issue: 3 year: 2019 ident: 10.1016/j.ijbiomac.2024.134814_bb0160 article-title: Impact of purification on iota carrageenan as solid polymer electrolyte publication-title: Arab. J. Chem. doi: 10.1016/j.arabjc.2018.06.008 contributor: fullname: Ghani – volume: 272 start-page: 5950 issue: 23 year: 2005 ident: 10.1016/j.ijbiomac.2024.134814_bb0195 article-title: Structures for amyloid fibrils publication-title: FEBS J. doi: 10.1111/j.1742-4658.2005.05025.x contributor: fullname: Makin – volume: 23 start-page: 139 issue: 3 year: 2016 ident: 10.1016/j.ijbiomac.2024.134814_bb0205 article-title: Insulin amyloid at injection sites of patients with diabetes publication-title: Amyloid doi: 10.1080/13506129.2016.1179183 contributor: fullname: Nilsson – volume: 98 start-page: 639 issue: 5 year: 2010 ident: 10.1016/j.ijbiomac.2024.134814_bb0020 article-title: Mechanisms of amyloid fibril formation by proteins publication-title: Curr. Sci. contributor: fullname: Kumar – volume: 12 start-page: 311 issue: 4 year: 2005 ident: 10.1016/j.ijbiomac.2024.134814_bb0035 article-title: The role of insulin, insulin growth factor, and insulin-degrading enzyme in brain aging and Alzheimer’s disease publication-title: Neural Plast. doi: 10.1155/NP.2005.311 contributor: fullname: Messier – volume: 49 start-page: 832 issue: 12 year: 2011 ident: 10.1016/j.ijbiomac.2024.134814_bb0105 article-title: Biomedical applications of biodegradable polymers publication-title: J Polym Sci B doi: 10.1002/polb.22259 contributor: fullname: Ulery – volume: 4 start-page: 1 issue: 1 year: 2021 ident: 10.1016/j.ijbiomac.2024.134814_bb0110 article-title: Nanoencapsulated myricetin to improve antioxidant activity and bioavailability: a study on zebrafish embryos publication-title: Chemistry doi: 10.3390/chemistry4010001 contributor: fullname: Agraharam – volume: 17 start-page: 366 issue: 3 year: 2024 ident: 10.1016/j.ijbiomac.2024.134814_bb0115 article-title: Niosomal bupropion: exploring therapeutic frontiers through behavioral profiling publication-title: Pharmaceuticals doi: 10.3390/ph17030366 contributor: fullname: Harini – volume: 14 start-page: 3540 issue: 18 year: 2023 ident: 10.1016/j.ijbiomac.2024.134814_bb0230 article-title: κ-Carrageenan oligosaccharides protect nerves by regulating microglial autophagy in Alzheimer’s disease publication-title: ACS Chem. Nerosci. doi: 10.1021/acschemneuro.3c00460 contributor: fullname: Sun – volume: 112 start-page: 1248 year: 2018 ident: 10.1016/j.ijbiomac.2024.134814_bb0240 article-title: In vitro activities of kappa-carrageenan isolated from red marine alga Hypnea musciformis: antimicrobial, anticancer and neuroprotective potential publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2018.02.029 contributor: fullname: Souza – volume: 15 start-page: 285 issue: 1 year: 2017 ident: 10.1016/j.ijbiomac.2024.134814_bb0235 article-title: κ-Carrageenan-derived pentasaccharide attenuates Aβ25-35-induced apoptosis in SH-SY5Y cells via suppression of the JNK signaling pathway publication-title: Mol. Med. Rep. doi: 10.3892/mmr.2016.6006 contributor: fullname: Liu – volume: 57 start-page: 503 issue: 2 year: 2009 ident: 10.1016/j.ijbiomac.2024.134814_bb0125 article-title: Amyloid-degrading ability of nattokinase from Bacillus subtilis natto publication-title: J. Agric. Food Chem. doi: 10.1021/jf803072r contributor: fullname: Hsu – volume: 10 start-page: 3466 issue: 13 year: 2022 ident: 10.1016/j.ijbiomac.2024.134814_bb0060 article-title: Fatty acid-based polymeric micelles to ameliorate amyloidogenic disorders publication-title: Biomater. Sci. doi: 10.1039/D2BM00359G contributor: fullname: Bera – volume: 53 start-page: 310 issue: 3 year: 2021 ident: 10.1016/j.ijbiomac.2024.134814_bb0220 article-title: Zebrafish as an animal model for biomedical research publication-title: Exp. Mol. Med. doi: 10.1038/s12276-021-00571-5 contributor: fullname: Choi – volume: 56 start-page: 501 year: 2015 ident: 10.1016/j.ijbiomac.2024.134814_bb0145 article-title: Studies on polymer-coated zinc oxide nanoparticles: UV-blocking efficacy and in vivo toxicity publication-title: Mater. Sci. Eng. C doi: 10.1016/j.msec.2015.07.017 contributor: fullname: Girigoswami – volume: 10 start-page: 12 issue: 1 year: 2024 ident: 10.1016/j.ijbiomac.2024.134814_bb0075 article-title: Biological activities of carrageenan from red algae: a mini review publication-title: Curr. Pharmacol. Rep. doi: 10.1007/s40495-023-00348-6 contributor: fullname: Udayakumar – volume: 20 start-page: 419 issue: 7 year: 2022 ident: 10.1016/j.ijbiomac.2024.134814_bb0085 article-title: Eco-friendly extraction, structure, and gel properties of ι-carrageenan extracted using Ca (OH) 2 publication-title: Mar. Drugs doi: 10.3390/md20070419 contributor: fullname: Jiang – volume: 19 start-page: 174 issue: 1 year: 2015 ident: 10.1016/j.ijbiomac.2024.134814_bb0200 article-title: Insulin-derived amyloidosis publication-title: Indian J. Endocrinol. Metab. doi: 10.4103/2230-8210.146879 contributor: fullname: Gupta – volume: 6 start-page: 351 issue: 4 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0030 article-title: Insulin-derived amyloidosis: the insulin ball, amyloidoma publication-title: JAAD Case Rep. doi: 10.1016/j.jdcr.2020.02.011 contributor: fullname: Samlaska – volume: 57 year: 2024 ident: 10.1016/j.ijbiomac.2024.134814_bb0170 article-title: Anticancer potential of nanoformulated extract of Passiflora incarnata leaves publication-title: Biocatal. Agric. Biotechnol. doi: 10.1016/j.bcab.2024.103109 contributor: fullname: Deepika – ident: 10.1016/j.ijbiomac.2024.134814_bb0130 – volume: 146 year: 2024 ident: 10.1016/j.ijbiomac.2024.134814_bb0095 article-title: Rheological investigation of the network structure in mixed gels of kappa and iota carrageenan publication-title: Food Hydrocoll. doi: 10.1016/j.foodhyd.2023.109298 contributor: fullname: Bhattacharyya – volume: 10 start-page: 1232 issue: 6 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0245 article-title: Nutraceutical vegetable oil nanoformulations for prevention and management of diseases publication-title: Nanomaterials doi: 10.3390/nano10061232 contributor: fullname: Vergallo – volume: 134 start-page: 1 issue: 2 year: 2022 ident: 10.1016/j.ijbiomac.2024.134814_bb0185 article-title: The potential of lumbrokinase and serratiopeptidase for the degradation of Aβ 1–42 peptide–an in vitro and in silico approach publication-title: Int. J. Neurosci. contributor: fullname: Metkar – volume: 10 start-page: 9446 issue: 45 year: 2022 ident: 10.1016/j.ijbiomac.2024.134814_bb0040 article-title: Polyisobutylene-based glycopolymers as potent inhibitors for in vitro insulin aggregation publication-title: J. Mater. Chem. B doi: 10.1039/D2TB01856J contributor: fullname: Dey – volume: 70 start-page: 728 year: 2017 ident: 10.1016/j.ijbiomac.2024.134814_bb0135 article-title: In vitro and in vivo insulin amyloid degradation mediated by Serratiopeptidase publication-title: Mater. Sci. Eng. C doi: 10.1016/j.msec.2016.09.049 contributor: fullname: Metkar – volume: 254 year: 2024 ident: 10.1016/j.ijbiomac.2024.134814_bb0070 article-title: Chitosan oligosaccharides inhibit the fibrillation of insulin and disassemble its preformed fibrils publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2023.127857 contributor: fullname: Kalitnik – volume: 35 start-page: 505 year: 2019 ident: 10.1016/j.ijbiomac.2024.134814_bb0155 article-title: Low molecular weight sulfated chitosan: neuroprotective effect on rotenone-induced in vitro Parkinson’s disease publication-title: Neurotox. Res. doi: 10.1007/s12640-018-9978-z contributor: fullname: Manigandan – volume: 279 start-page: 22715 issue: 21 year: 2004 ident: 10.1016/j.ijbiomac.2024.134814_bb0175 article-title: Protein phosphatase-2Cα as a positive regulator of insulin sensitivity through direct activation of phosphatidylinositol 3-kinase in 3T3-L1 adipocytes* publication-title: J. Biol. Chem. doi: 10.1074/jbc.M313745200 contributor: fullname: Yoshizaki – volume: 163 start-page: 128 year: 2020 ident: 10.1016/j.ijbiomac.2024.134814_bb0010 article-title: Attenuation of subcutaneous insulin induced amyloid mass in vivo using Lumbrokinase and Serratiopeptidase publication-title: Int. J. Biol. Macromol. doi: 10.1016/j.ijbiomac.2020.06.256 contributor: fullname: Metkar – volume: 18 start-page: 723 issue: 9 year: 2019 ident: 10.1016/j.ijbiomac.2024.134814_bb0180 article-title: Prion peptide 106-126 degradation potential of Serratiopetidase and lumbrokinase-an in vitro and in silico perspective publication-title: CNS Neurol. Disorders-Drug Targets (Formerly Curr. Drug Targets-CNS Neurol. Disorders) doi: 10.2174/1871527318666191021150002 contributor: fullname: Metkar – volume: 11 start-page: 6857 issue: 1 year: 2021 ident: 10.1016/j.ijbiomac.2024.134814_bb0025 article-title: Degradation of insulin amyloid by antibiotic minocycline and formation of toxic intermediates publication-title: Sci. Rep. doi: 10.1038/s41598-021-86001-y contributor: fullname: Mori – volume: 6 start-page: 8705 issue: 10 year: 2023 ident: 10.1016/j.ijbiomac.2024.134814_bb0050 article-title: Amino acid-based polymer-coated silver nanoparticles as insulin fibril inhibitors publication-title: ACS Appl. Nano Mater. doi: 10.1021/acsanm.3c01078 contributor: fullname: Bera – volume: 12 start-page: 20884 issue: 1 year: 2022 ident: 10.1016/j.ijbiomac.2024.134814_bb0225 article-title: Optical transparency and label-free vessel imaging of zebrafish larvae in shortwave infrared range as a tool for prolonged studying of cardiovascular system development publication-title: Sci. Rep. doi: 10.1038/s41598-022-25386-w contributor: fullname: Volkov |
| SSID | ssj0006518 |
| Score | 2.4621816 |
| Snippet | Amyloids, with their β-sheet-rich structure, contribute to diabetes, neurodegenerative diseases, and amyloidosis by aggregating within diverse anatomical... |
| SourceID | proquest crossref pubmed elsevier |
| SourceType | Aggregation Database Index Database Publisher |
| StartPage | 134814 |
| SubjectTerms | Amyloid degradation Amyloidosis Insulin amyloid Iota carrageenan Neurodegenerative disease Thioflavin T Type II diabetes |
| Title | Exploring the amyloid degradation potential of nanoformulated carrageenan-bridging in vitro and in vivo perspectives |
| URI | https://dx.doi.org/10.1016/j.ijbiomac.2024.134814 https://www.ncbi.nlm.nih.gov/pubmed/39168227 https://www.proquest.com/docview/3095676770 |
| Volume | 279 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwED5BGWBBvCkvGYk1bR5OnIyoAhUQTCCxWY4fUiqRVCUw8tu5y6PAgBgY48SOc-fcfU7uuwO4MDoQQtnIc0mWetzlystzqvWSKa2sS3AJEVH4_iGZPvHb5_h5BSY9F4bCKjvb39r0xlp3LeNOmuN5UYwpLAndU0RJuhAEZOkqrKE7CtMBrF3e3E0flgY5iZvPfHS9Rx2-EYVno2JGPHdF2QxDPgqIl8p_81G_YdDGF11vwWYHItllO89tWLHlDqxP-tptu1AvQ-sYAjymXnBbXhhmKDNEW0SJzauaAoVwmMqxUpUVoVeq5WUN02qxQDtjsdlrGF00UFGy96JeVEyVpj14r9j8i6v5ugdP11ePk6nX1VfwdMjj2su4aJi1vo96dJyb2IRaCD-x6LVs6htheKwEzyOFb2ni8GwUaYdbRqG0j95vHwZlVdpDYLhLi1UUpkoHmtvAZalxgdCxC2PncIQhjHuJynmbRkP28WUz2etAkg5kq4MhZL3g5Y8FIdHW_9n3vNeURMHTLxBV2urtVUaUd1Ek-JBDOGhVuJwPUZARLomjf9z5GDboqCUrnsCgXrzZU0QtdX4Gq6OP4Kxbm59Oxe5e |
| link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV25TsQwEB1xFNAgbpbTSLRhczhxUqIVaLm2AonOcnxIWYlktQS-n5kcCxSIgjJ27Dgee-Y5mTcDcGF0IISykeeSLPW4y5WX55TrJVNaWZfgEiKi8OMkGT_zu5f4ZQlGPReG3Co73d_q9EZbdyXDbjaHs6IYklsSmqeIgnQhCMjSZVhFNJDh7ly9ur0fTxYKOYmbz3x0v0cNvhGFp5fFlHjuiqIZhvwyIF4q_81G_YZBG1t0swkbHYhkV-04t2DJltuwNupzt-1AvXCtYwjwmHrFY3lhmKHIEG0SJTaranIUwm4qx0pVVoReKZeXNUyr-Rz1jMVir2F0UUdFyT6Kel4xVZr24qNisy-u5tsuPN9cP43GXpdfwdMhj2sv46Jh1vo-ytFxbmITaiH8xKLVsqlvhOGxEjyPFO7SxGFtFGmHR0ahtI_Wbw9Wyqq0B8DwlBarKEyVDjS3gctS4wKhYxfGzmEPAxj2MypnbRgN2fuXTWUvA0kykK0MBpD1Ey9_LAiJuv7Ptue9pCROPP0CUaWt3t9kRHEXRYIvOYD9VoSL8RAFGeGSOPzHk89gbfz0-CAfbif3R7BONS1x8RhW6vm7PUEEU-en3Qr9BBPW8FI |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Exploring+the+amyloid+degradation+potential+of+nanoformulated+carrageenan-bridging+in+vitro+and+in+vivo+perspectives&rft.jtitle=International+journal+of+biological+macromolecules&rft.au=Udayakumar%2C+Saranya&rft.au=Metkar%2C+Sanjay+Kisan&rft.au=Girigoswami%2C+Agnishwar&rft.au=Deepika%2C+Balasubramanian&rft.date=2024-11-01&rft.eissn=1879-0003&rft.volume=279&rft.issue=Pt+1&rft.spage=134814&rft_id=info:doi/10.1016%2Fj.ijbiomac.2024.134814&rft_id=info%3Apmid%2F39168227&rft.externalDocID=39168227 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0141-8130&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0141-8130&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0141-8130&client=summon |